Table 2. Univariate and multivariate Cox regression models.
Group | Univariate analysis | Multivariate analysis* | Multivariate analysis after multiple imputation* | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | HR | 95% CI | P-value | |
No WRF/more reduction | 1 (reference) | 1 (reference) | 1 (reference) | ||||||
No WRF/less reduction | 1.83 | 1.29–2.56 | <0.001 | 1.61 | 1.10–2.37 | 0.014 | 1.15 | 0.90–1.47 | 0.264 |
WRF/more reduction | 0.84 | 0.38–1.87 | 0.683 | 0.77 | 0.34–1.75 | 0.537 | 1.00 | 0.64–1.58 | 0.986 |
WRF/less reduction | 4.50 | 2.78–7.28 | <0.001 | 3.34 | 1.95–5.73 | <0.001 | 2.15 | 1.53–3.02 | <0.001 |
*Adjustment was performed for age, gender, New York Heart Association functional class, systolic blood pressure, heart rate, history of heart failure, history of diabetes, left ventricular ejection fraction, prescription of beta blocker, prescription of angiotensin inhibitor or angiotensin II receptor blocker at admission, hemoglobin, serum sodium, serum creatinine, blood urea nitrogen (BUN) and BNP at baseline, as well as C-reactive protein.